Form 4 for MNPR Monopar Therapeutics
Accepted 2021-07-02 00:00:00 ET · period of report 2021-06-30 · accession 0001654954-21-007604 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-02 | 2021-06-30 | MNPR | Anderson Raymond | Dir | M - OptEx | — | +752 | 3,792 | +25% | — |
| D | 2021-07-02 | 2021-06-30 | MNPR | Anderson Raymond | Dir | M - OptEx | $0.00 | -752 | 1,502 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-30 | M | A | 752 | — | 3,792 | D | — | — | (F1) Represents shares acquired on vesting and settlement of restricted stock units. |
| 2 | Derivative | Restricted Stock Units | 2021-06-30 | M | D | 752 | $0.00 | 1,502 | D | — · — to — | 752 Common Stock | (F1) Represents shares acquired on vesting and settlement of restricted stock units. (F2) On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. |